APA (7th ed.) Citation

SH, C., YE, L., LYL, H., CK, C., CL, L., YH, L., . . . JJ, H. (2020). Discovery of T-1101 tosylate as a first-in-class clinical candidate for Hec1/Nek2 inhibition in cancer therapy. European journal of medicinal chemistry, 191, 112118. https://doi.org/10.1016/j.ejmech.2020.112118

Chicago Style (17th ed.) Citation

SH, Chuang, et al. "Discovery of T-1101 Tosylate as a First-in-class Clinical Candidate for Hec1/Nek2 Inhibition in Cancer Therapy." European Journal of Medicinal Chemistry 191 (2020): 112118. https://doi.org/10.1016/j.ejmech.2020.112118.

MLA (9th ed.) Citation

SH, Chuang, et al. "Discovery of T-1101 Tosylate as a First-in-class Clinical Candidate for Hec1/Nek2 Inhibition in Cancer Therapy." European Journal of Medicinal Chemistry, vol. 191, 2020, p. 112118, https://doi.org/10.1016/j.ejmech.2020.112118.